Our agile research team has miles of experience.

We treat every project as a custom project.
Deep knowledge of pre-clinical technologies and methods.
Home 2017-12-11T16:17:53+00:00


Aragen’s RapTr™ Cell Line Development services combine the proven CHO-DG44 host cell line and vector combination with an innovative clone selection process that delivers high titers at every stage from Discovery to the Clinic.

Antibody Engineering and Therapeutics
December 11-15, 2017 | San Diego, CA

Peptalk: The Protein Science Week
January 8-12, 2018 | San Diego, CA

Press Releases

Aragen Bioscience Announces AAALAC Accreditation

RapTr Cell Line Development Services Introduced